Abstract:The viral capsid performs critical functions during HIV-1 infection and is a validated target for antiviral therapy. Previous studies have established that the proper structure and stability of the capsid are required for efficient HIV-1 reverse transcription in target cells. Moreover, it has recently been demonstrated that permeabilized virions and purified HIV-1 cores undergo efficient reverse transcription in vitro when the capsid is stabilized by addition of the host cell metabolite inositol hexakisphosphate (IP6). However, the molecular mechanism by which the capsid promotes reverse transcription is undefined. Here we show that wild type HIV-1 virions can undergo efficient reverse transcription in vitro in the absence of a membrane-permeabilizing agent. This activity, originally termed "natural endogenous reverse transcription" (NERT), depends on expression of the viral envelope glycoprotein during virus assembly and its incorporation into virions. Truncation of the gp41 cytoplasmic tail markedly reduced NERT activity, suggesting that gp41 licenses the entry of nucleotides into virions. By contrast to reverse transcription in permeabilized virions, NERT required neither the addition of IP6 nor a mature capsid, indicating that an intact viral membrane can substitute for the function of the viral capsid during reverse transcription in vitro . Collectively, these results demonstrate that the viral capsid functions as a nanoscale container for reverse transcription during HIV-1 infection. HIV-1 infection is critically dependent on reverse transcription, or copying of the viral RNA into DNA, following entry of the viral core in target cells. Reverse transcription depends on the stability of the capsid, yet the precise function the capsid serves during the reaction has not been established. Here we show that the viral capsid functions as a container for the reaction. Addition of dNTPs to intact virions in the absence of a permeabilizing agent resulted in efficient reverse transcription (NERT). Analysis of HIV-1 mutants revealed that the reaction depends on the cytoplasmic domain of gp41, confirming an earlier report. By contrast to the reaction in permeabilized virions, NERT required neither a stable nor a mature capsid, nor was it affected by the capsid-destabilizing inhibitor PF74. NERT also occurred in HIV-1 particles produced in various T cell lines and in simian immunodeficiency particles. Our results demonstrate that the capsid serves a container role in HIV-1 reverse transcription and suggest that it remains fully intact during reverse transcription in target cells. They further suggest that the gp41 protein can permeabilize membranes to nucleotides, potentially contributing to viral dissemination and pathogenesis in the infected host.

HIV-1 RNAs whose transcription initiates from the third deoxyguanosine of GGG tract in the 5′ long terminal repeat serve as a dominant genome for efficient provirus DNA formation

Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA

HIV-1 usurps transcription start site heterogeneity of host RNA polymerase II to maximize replication fitness

HIV-1 single transcription start site mutants display complementary replication functions that are restored by reversion

Intragenic proviral elements support transcription of defective HIV-1 proviruses

HIV-1 RNA genome packaging: it's G-rated

Translation of HIV-1 unspliced RNA is regulated by 5' untranslated region structure

Transcription of HIV-1 at sites of intact latent provirus integration

RNAa Induced by TATA Box-Targeting MicroRNAs.

A Novel HIV-1-encoded Microrna Enhances Its Viral Replication by Targeting the TATA Box Region

Determinants of the interaction between the 5'-leader of HIV-1 genome and human lysyl-tRNA synthetase in reverse transcription primer release process

HIV-1 virus cycle replication: a review of RNA polymerase II transcription, alternative splicing and protein synthesis

Selective packaging of HIV-1 RNA genome is guided by the stability of 5' untranslated region polyA stem

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes

The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

The HIV-1 Rev/RRE System is Required for HIV-1 5' UTR Cis Elements to Augment Encapsidation of Heterologous RNA into HIV-1 Viral Particles

Characterizing Transcripts of HIV-1 Different Substrains Using Direct RNA Sequencing

Human immunodeficiency virus-1 induces host genomic R-loop and preferentially integrates its genome near the R-loop regions

HIV-1 Transcripts Use IRES-Initiation under Conditions Where Cap-Dependent Translation Is Restricted by Poliovirus 2A Protease